{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:17:40Z","timestamp":1786112260583,"version":"build-2736575974"},"reference-count":74,"publisher":"Bioscientifica","issue":"8","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Post-bariatric hypoglycaemia (PBH) is an increasingly recognised complication of bariatric and metabolic surgery, which can markedly impair quality of life and jeopardise the long-term benefits of surgery. This review summarises the current evidence on the epidemiology, pathophysiology, and management of PBH, with a particular focus on mechanism-based treatment strategies. We first point out the limitations of existing epidemiological data and then outline a practical diagnostic framework. We next review the evolving understanding of PBH as a heterogeneous, pathophysiology-driven syndrome arising from rapid nutrient delivery, exaggerated incretin responses, excessive insulin secretion, impaired glucagon secretion, and emerging contributors, such as postprandial serotonin hypersecretion, bile acid signalling, and microbiome change. On this basis, we review therapeutic options by mechanistic target, covering dietary and lifestyle interventions, acarbose, SGLT inhibition, somatostatin analogues, GLP-1 receptor antagonists, diazoxide, glucagon-based approaches, and experimental serotonin receptor antagonism, and briefly discuss agents with limited supportive evidence. Finally, we explore key knowledge gaps and future directions, including the need for long-term prospective data, precision medicine approaches, rational combination therapy, and greater integration of continuous glucose monitoring and digital decision support. Mechanism-based, multidisciplinary care from bariatric physicians, dietitians, and surgeons offers the best prospect of managing PBH, preserving quality of life, and safeguarding the metabolic benefits of bariatric surgery.<\/jats:p>","DOI":"10.1530\/ec-25-0850","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:43:39Z","timestamp":1782744219000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":0,"title":["Post-bariatric hypoglycaemia: from altered gut physiology to targeted therapies"],"prefix":"10.1530","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1166-6281","authenticated-orcid":true,"given":"Wei","family":"Yang","sequence":"first","affiliation":[{"name":"Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London 1 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia M-M","family":"Tan","sequence":"additional","affiliation":[{"name":"Section of Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London 1 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026080510464045600_bib1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/oby.21042","article-title":"Prevalence of and risk factors for hypoglycaemic symptoms after gastric bypass and sleeve gastrectomy","volume":"23","author":"Lee","year":"2015","journal-title":"Obesity"},{"key":"2026080510464045600_bib2","article-title":"Society for endocrinology guidelines for the diagnosis and management of post bariatric hypoglycaemia","volume":"13","author":"Hazlehurst","year":"2024","journal-title":"Endocr Connections"},{"key":"2026080510464045600_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3750","article-title":"Post bariatric surgery hypoglycaemia: nutritional, pharmacological and surgical perspectives","volume":"40","author":"Rossini","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"2026080510464045600_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3122\/jabfm.2024.240335R1","article-title":"Diagnosis and management of post-bariatric hypoglycemia","volume":"38","author":"Lawler","year":"2025","journal-title":"J Am Board Fam Med"},{"key":"2026080510464045600_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S2213-8587(15)00460-X","article-title":"The rollercoaster of postbariatric hypoglycaemia","volume":"4","author":"Patti","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026080510464045600_bib6","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.soard.2016.04.017","article-title":"Prevalence, severity, and predictors of symptoms of dumping and hypoglycaemia after Roux-en-Y gastric bypass","volume":"12","author":"Nielsen","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"2026080510464045600_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.soard.2014.11.003","article-title":"Hypoglycaemia after Roux-en-Y gastric bypass: detection rates of continuous glucose monitoring versus mixed meal test","volume":"11","author":"Kefurt","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"2026080510464045600_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3949\/ccjm.92a.24033","article-title":"Hypoglycaemia after bariatric surgery: management updates","volume":"92","author":"Iqbal","year":"2025","journal-title":"Cleve Clin J Med"},{"key":"2026080510464045600_bib9","article-title":"Postbariatric hypoglycemia in symptomatic versus asymptomatic patients: proposals for clinical assessments","volume":"10","author":"Hemmingsson","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026080510464045600_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/dc20-1609","article-title":"Roux-en-Y gastric bypass increases glycemic variability and time in hypoglycemia in patients with obesity and prediabetes or type 2 diabetes: a prospective cohort study.","volume":"44","author":"Ilesanmi","year":"2021","journal-title":"Diabetes Care"},{"key":"2026080510464045600_bib11","first-page":"442","article-title":"Hypoglycaemia post bariatric surgery: drugs with different mechanisms of action to treat a unique disorder","volume":"67","author":"Carpentieri","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"2026080510464045600_bib12","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1210\/jc.2017-01695","article-title":"Incidence of hypoglycaemia after gastric bypass vs sleeve gastrectomy: a randomized trial","volume":"103","author":"Capristo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080510464045600_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41574-020-0357-5","article-title":"International consensus on the diagnosis and management of dumping syndrome","volume":"16","author":"Scarpellini","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"2026080510464045600_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.orcp.2015.07.003","article-title":"Recognition and management of hyperinsulinemic hypoglycaemia after bariatric surgery","volume":"10","author":"Malik","year":"2016","journal-title":"Obes Res Clin Pract"},{"key":"2026080510464045600_bib15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/dom.15096","article-title":"Continuous glucose monitoring in patients with post-bariatric hypoglycaemia reduces hypoglycaemia and glycaemic variability","volume":"25","author":"Cummings","year":"2023","journal-title":"Diabetes Obes Metabol"},{"key":"2026080510464045600_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf106","article-title":"Continuous glucose monitoring in patients with postbariatric hypoglycemia: effect on hypoglycemia and quality of life","volume":"9","author":"Turk","year":"2025","journal-title":"J Endocr Soc"},{"key":"2026080510464045600_bib17","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/dom.13796","article-title":"Postprandial hypoglycaemia after Roux-en-Y gastric bypass and the effects of acarbose, sitagliptin, verapamil, liraglutide and pasireotide","volume":"21","author":"\u00d8hrstr\u00f8m","year":"2019","journal-title":"Diabetes Obes Metabol"},{"key":"2026080510464045600_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1089\/dia.2023.0036","article-title":"Randomized, double-blind, placebo-controlled crossover trial of once daily empagliflozin 25 mg for the treatment of postprandial hypoglycaemia after Roux-en-Y gastric bypass","volume":"25","author":"Ferreira","year":"2023","journal-title":"Diabetes Technol Therapeut"},{"key":"2026080510464045600_bib19","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/dc23-1193","article-title":"Dasiglucagon treatment for postprandial hypoglycemia after gastric bypass: a randomized, double-blind, placebo-controlled Trial","volume":"46","author":"Nielsen","year":"2023","journal-title":"Diabetes Care"},{"key":"2026080510464045600_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15320","article-title":"Canagliflozin or acarbose versus placebo to ameliorate post-bariatric hypoglycaemia \u2013 the HypoBar I randomized clinical trial protocol","volume":"41","author":"Lobato","year":"2024","journal-title":"Diabet Med"},{"key":"2026080510464045600_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cgh.2019.03.047","article-title":"Changes in time of gastric emptying after surgical and endoscopic bariatrics and weight loss: a systematic review and meta-analysis","volume":"18","author":"Vargas","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026080510464045600_bib22","article-title":"British obesity and metabolic surgery society guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery\u20142020 update","volume":"21","author":"O\u2019Kane","year":"2020","journal-title":"Obesity Reviews"},{"key":"2026080510464045600_bib23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.soard.2008.05.005","article-title":"Postgastric bypass hyperinsulinemic hypoglycaemia syndrome: characterization and response to a modified diet","volume":"4","author":"Kellogg","year":"2008","journal-title":"Surg Obes Relat Dis"},{"key":"2026080510464045600_bib24","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.soard.2017.09.004","article-title":"Effect of meal size and texture on gastric pouch emptying and glucagon-like peptide 1 after gastric bypass surgery","volume":"13","author":"Stano","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"2026080510464045600_bib25","doi-asserted-by":"crossref","first-page":"E540","DOI":"10.1152\/ajpendo.00176.2023","article-title":"The effects of postprandial exercise and meal glycaemic index on plasma glucose and glucoregulatory hormone responses after Roux-en-Y gastric bypass","volume":"325","author":"Ternhamar","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026080510464045600_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.diabet.2011.04.003","article-title":"Post-bypass hypoglycaemia: a review of current findings","volume":"37","author":"Ritz","year":"2011","journal-title":"Diabetes Metab"},{"key":"2026080510464045600_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11695-011-0581-0","article-title":"Acarbose improves hypoglycaemia following gastric bypass surgery without increasing glucagon-like peptide-1 levels","volume":"22","author":"Valderas","year":"2012","journal-title":"Obes Surg"},{"key":"2026080510464045600_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4158\/EP12281.RA","article-title":"Post-gastric-bypass hypoglycaemia successfully treated with alpha-glucosidase inhibitor therapy","volume":"19","author":"Frankhouser","year":"2013","journal-title":"Endocr Pract"},{"key":"2026080510464045600_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4158\/EP14118.OR","article-title":"Evaluation, medical therapy, and course of adult persistent hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass surgery: a case series.","volume":"21","author":"Mordes","year":"2015","journal-title":"Endocrine Practice"},{"key":"2026080510464045600_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/DMSO.S123244","article-title":"Acarbose promotes remission of both early and late dumping syndromes in post-bariatric patients","volume":"9","author":"Cadegiani","year":"2016","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2026080510464045600_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/dom.14920","article-title":"Medical and surgical treatment of postbariatric hypoglycaemia: retrospective data from daily practice","volume":"25","author":"de Heide","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"2026080510464045600_bib32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000442764","article-title":"Hyperinsulinemic hypoglycaemia after bariatric surgery: diagnosis and management experience from a Spanish multicenter registry","volume":"9","author":"Vilarrasa","year":"2016","journal-title":"Obes Facts"},{"key":"2026080510464045600_bib33","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s11695-008-9569-9","article-title":"Post-prandial hypoglycemia after bariatric surgery: pharmacological treatment with verapamil and acarbose","volume":"18","author":"Moreira","year":"2008","journal-title":"Obes Surg"},{"key":"2026080510464045600_bib34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.soard.2019.03.031","article-title":"Possible relation between partial small bowel obstruction and severe postprandial reactive hypoglycaemia after Roux-en-Y gastric bypass","volume":"15","author":"Laurenius","year":"2019","journal-title":"Surg Obes Relat Dis"},{"key":"2026080510464045600_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1053\/j.gastro.2013.11.044","article-title":"Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycaemia after gastric bypass","volume":"146","author":"Salehi","year":"2014","journal-title":"Gastroenterology"},{"key":"2026080510464045600_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metabol"},{"key":"2026080510464045600_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000515598","article-title":"Canagliflozin: a new therapeutic option in patients that present postprandial hyperinsulinemic hypoglycaemia after Roux-en-Y gastric bypass: a pilot study","volume":"14","author":"Ciudin","year":"2021","journal-title":"Obes Facts"},{"key":"2026080510464045600_bib38","doi-asserted-by":"crossref","first-page":"E956","DOI":"10.1152\/ajpendo.00023.2020","article-title":"The effect of acute dual SGLT1\/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery","volume":"318","author":"Martinussen","year":"2020","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026080510464045600_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cmet.2020.02.013","article-title":"Postprandial hypoglycaemia in patients after gastric bypass surgery is mediated by glucose-induced IL-1\u03b2","volume":"31","author":"Hepprich","year":"2020","journal-title":"Cell Metab"},{"key":"2026080510464045600_bib40","article-title":"Successful use of canagliflozin for treatment of post-bariatric surgery hypoglycaemia unresponsive to other therapy","volume":"50","author":"Abouglila","year":"2017","journal-title":"Endocr Abstr"},{"key":"2026080510464045600_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1193696","article-title":"Case report: post-gastrectomy reactive hyperinsulinemic hypoglycaemia: glucose trends before and after canagliflozin treatment","volume":"14","author":"Bellastella","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026080510464045600_bib42","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1007\/s11695-022-06119-4","article-title":"SGLT2 inhibition with empagliflozin as a possible therapeutic option for postprandial hypoglycaemia after bariatric surgery","volume":"32","author":"Carpentieri","year":"2022","journal-title":"Obes Surg"},{"key":"2026080510464045600_bib43","article-title":"FRI605 inhibition of intestinal SGLT1 with mizagliflozin for the treatment of post-bariatric hypoglycemia","volume":"7","author":"Lawler","year":"2023","journal-title":"J Endocr Soc"},{"key":"2026080510464045600_bib44","volume-title":"Avexitide for treating post-bariatric hypoglycaemia","author":"NIHR Innovation Observatory","year":"2025"},{"key":"2026080510464045600_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156220","article-title":"A phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avexitide in post-bariatric hypoglycemia (LUCIDITY)","volume":"168","author":"Miller","year":"2025","journal-title":"Metabolism"},{"key":"2026080510464045600_bib46","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s11695-019-04248-x","article-title":"A low dose of pasireotide prevents hypoglycaemia in Roux-en-Y gastric bypass-operated individuals","volume":"30","author":"\u00d8hrstr\u00f8m","year":"2020","journal-title":"Obes Surg"},{"key":"2026080510464045600_bib47","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/archsurg.1991.01410340073010","article-title":"Control of dumping symptoms by somatostatin analogue in patients after gastric surgery","volume":"126","author":"Gray","year":"1991","journal-title":"Arch Surg"},{"key":"2026080510464045600_bib48","first-page":"252","article-title":"Octreotide prevents hypoglycaemia in patients prone to post-prandial hypoglycaemia following bariatric surgery","volume":"11","author":"Whyte","year":"2010","journal-title":"Obes Rev"},{"key":"2026080510464045600_bib49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.endinu.2021.09.003","article-title":"Recommendations for the diagnosis and treatment of hypoglycaemia after bariatric surgery","volume":"69","author":"Vilarrasa","year":"2022","journal-title":"Endocrinol Diabetes Nutr"},{"key":"2026080510464045600_bib50","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1177\/2050640619862166","article-title":"Efficacy and safety of lanreotide in postoperative dumping syndrome: a phase II randomised and placebo-controlled study","volume":"7","author":"Wauters","year":"2019","journal-title":"United European Gastroenterol J"},{"key":"2026080510464045600_bib51","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/apt.14664","article-title":"Safety and efficacy of pasireotide in dumping syndrome \u2013 results from a phase 2, multicentre study","volume":"47","author":"Tack","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"2026080510464045600_bib52","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cgh.2008.11.025","article-title":"Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping","volume":"7","author":"Arts","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026080510464045600_bib53","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa043690","article-title":"Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery","volume":"353","author":"Service","year":"2005","journal-title":"N Engl J Med"},{"key":"2026080510464045600_bib54","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1007\/s00125-005-1933-x","article-title":"Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia","volume":"48","author":"Patti","year":"2005","journal-title":"Diabetologia"},{"key":"2026080510464045600_bib55","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.2337\/dc06-0392","article-title":"Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased \u03b2-cell turnover","volume":"29","author":"Meier","year":"2006","journal-title":"Diabetes Care"},{"key":"2026080510464045600_bib56","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1210\/jc.2009-1628","article-title":"Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery","volume":"95","author":"McLaughlin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080510464045600_bib57","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/dom.14048","article-title":"Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9\u201339) for treatment of post-bariatric hypoglycaemia","volume":"22","author":"Tan","year":"2020","journal-title":"Diabetes Obes Metabol"},{"key":"2026080510464045600_bib58","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00125-016-4179-x","article-title":"Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia","volume":"60","author":"Craig","year":"2017","journal-title":"Diabetologia"},{"key":"2026080510464045600_bib59","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/dom.13078","article-title":"Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia","volume":"20","author":"Craig","year":"2018","journal-title":"Diabetes Obes Metabol"},{"key":"2026080510464045600_bib60","doi-asserted-by":"crossref","first-page":"e3235","DOI":"10.1210\/clinem\/dgab103","article-title":"PREVENT: a randomized, placebo-controlled crossover trial of avexitide for treatment of postbariatric hypoglycaemia","volume":"106","author":"Craig","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080510464045600_bib61","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1210\/clinem\/dgaf691","volume":"111","author":"Fabbrini","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080510464045600_bib62","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/oby.23600","article-title":"The efficacy of GLP-1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review","volume":"31","author":"Llewelyn","year":"2023","journal-title":"Obesity"},{"key":"2026080510464045600_bib63","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s11695-009-9888-5","article-title":"Successful medical management of status post-Roux-en-Y-gastric-bypass hyperinsulinemic hypoglycaemia","volume":"19","author":"Spanakis","year":"2009","journal-title":"Obes Surg"},{"key":"2026080510464045600_bib64","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00464-010-1001-6","article-title":"Management of postgastric bypass noninsulinoma pancreatogenous hypoglycaemia","volume":"24","author":"Mathavan","year":"2010","journal-title":"Surg Endosc"},{"key":"2026080510464045600_bib65","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/j.soard.2011.05.010","article-title":"Use of diazoxide in management of severe postprandial hypoglycaemia in patient after Roux-en-Y gastric bypass","volume":"9","author":"Gonzalez-Gonzalez","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"2026080510464045600_bib66","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/dia.2017.0298","article-title":"Design and clinical evaluation of a novel low-glucose prediction algorithm with mini-dose stable glucagon delivery in post-bariatric hypoglycaemia","volume":"20","author":"Laguna Sanz","year":"2018","journal-title":"Diabetes Technol Therapeut"},{"key":"2026080510464045600_bib67","doi-asserted-by":"crossref","first-page":"e1260","DOI":"10.1210\/clinem\/dgz197","article-title":"A randomized, placebo-controlled double-blind trial of a closed-loop glucagon system for postbariatric hypoglycaemia","volume":"105","author":"Mulla","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026080510464045600_bib68","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.2337\/dc21-2252","article-title":"Dasiglucagon effectively mitigates postbariatric postprandial hypoglycaemia: a randomized, double-blind, placebo-controlled, crossover trial","volume":"45","author":"Nielsen","year":"2022","journal-title":"Diabetes Care"},{"key":"2026080510464045600_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/JCI180157","article-title":"Postprandial metabolomics analysis reveals disordered serotonin metabolism in post-bariatric hypoglycaemia","volume":"134","author":"Ferraz-Bannitz","year":"2024","journal-title":"J Clin Investig"},{"key":"2026080510464045600_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jnutbio.2016.03.006","article-title":"Nutrient-induced glucagon-like peptide-1 release is modulated by serotonin","volume":"32","author":"Ripken","year":"2016","journal-title":"J Nutr Biochem"},{"key":"2026080510464045600_bib71","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.tips.2023.09.012","article-title":"Ligand selectivity hotspots in serotonin GPCRs","volume":"44","author":"Simon","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"2026080510464045600_bib72","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1530\/EJE-13-0504","article-title":"GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication?","volume":"169","author":"Abrahamsson","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"2026080510464045600_bib73","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/js.2019-00097","article-title":"Hypoglycaemia after gastric bypass successfully treated with calcium channel blockers: two case reports","volume":"3","author":"Ames","year":"2019","journal-title":"J Endocr Soc"},{"key":"2026080510464045600_bib74","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/dom.14665","article-title":"Pramlintide for post-bariatric hypoglycaemia","volume":"24","author":"Sheehan","year":"2022","journal-title":"Diabetes Obes Metabol"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/aop\/EC-25-0850\/EC-25-0850.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/aop\/EC-25-0850\/EC-25-0850.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0850\/519661\/ec-25-0850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-25-0850\/519661\/ec-25-0850.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:46:59Z","timestamp":1785941219000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/15\/8\/e250850\/77507\/Post-bariatric-hypoglycaemia-from-altered-gut"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":74,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-25-0850","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"e250850"}}